版本:
中国

BRIEF-Novelion Therapeutics says U.S. Patent Trial, appeal board issued written decision in inter partes review proceeding

March 7 Novelion Therapeutics Inc:

* Novelion Therapeutics - U.S. patent trial, appeal board issued written decision in inter partes review proceeding

* Novelion Therapeutics Inc - ptab affirms patentability of all claims on U.S. 7,932,268 and U.S. 8,618,135 lomitapide dosage regimen patents Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐